Neuronetics Shakes Up Leadership Team with New CFO and Key Departure
Event summary
- Neuronetics appoints Nir Naor as CFO effective July 23, 2026, bringing over 20 years of finance and life sciences experience.
- Cory Anderson promoted to Executive Vice President and General Manager of Greenbrook effective July 1, 2026.
- Andrew Macan, Chief Legal Officer, will step down effective August 15, 2026.
The big picture
Neuronetics' leadership changes reflect a strategic pivot towards financial discipline and operational excellence. The appointment of Nir Naor, with his track record in turning around life sciences companies, signals a focus on profitability and cash flow management. Meanwhile, the promotion of Cory Anderson underscores the importance of the Greenbrook clinic network to Neuronetics' overall strategy.
What we're watching
- Financial Discipline
- How Nir Naor's focus on profitable revenue growth and capital allocation will impact Neuronetics' financial strategy.
- Operational Excellence
- Whether Cory Anderson can sustain the growth of Greenbrook under his expanded leadership role.
- Leadership Transition
- The pace at which Neuronetics can integrate Andrew Macan's successor and maintain legal and regulatory compliance.